...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of some new 4-styryltetrazolo(1,5-a)quinoxaline and 1-substituted-4-styryl(1,2,4)triazolo(4,3-a)quinoxaline derivatives as potent anticonvulsants.
【24h】

Synthesis of some new 4-styryltetrazolo(1,5-a)quinoxaline and 1-substituted-4-styryl(1,2,4)triazolo(4,3-a)quinoxaline derivatives as potent anticonvulsants.

机译:合成一些新的4-苯乙烯基四唑(1,5-a)喹喔啉和1-取代的4-苯乙烯基(1,2,4)三唑并(4,3-a)喹喔啉衍生物作为有效的抗惊厥药。

获取原文
获取原文并翻译 | 示例
           

摘要

4-Methyltetrazolo[1,5-a]quinoxaline (3) was prepared by the azide cyclocondensation of 2-chloro-3-methylquinoxaline (2). The reaction of 3 with aromatic aldehydes furnished 4-styryltetrazolo[1,5-a]quinoxalines (4a-f). Compound 2, on treatment with hydrazine hydrate gave 2-hydrazino-3-methylquinoxaline (5). The ring closure of 5 was achieved by the reaction of orthoesters and trifluoroacetic acid to yield 4-methyl-1-(substituted)[1,2,4]triazolo[4,3-a]quinoxalines (7a-c). Further, reaction of 7a-c with different aromatic aldehydes furnished the title compounds, 4-styryl-1-(substituted)[1,2,4]triazolo[4,3-a]quinoxalines (8a-i) in good yield. In another scheme, the hydrazino compound 5 was treated with different aromatic aldehydes to yield corresponding N-arylidenehydrazino quinoxalines (6a-d). Further, the oxidative cyclization of hydrazones by nitrobenzene yielded 1-aryl-4-methyl[1,2,4]triazolo[4,3-a]quinoxalines (7d-g), which on condensation with aromatic aldehydes gave the title compounds, 1-aryl-4-styryl[1,2,4]triazolo[4,3-a]quinoxalines (8j-u). The newly synthesized compounds have been characterized by FTIR, (1)H NMR, (13)C NMR and mass spectral data, followed by elemental analysis. Some of the compounds were screened for in vivo anticonvulsant activity. Few of them exhibited promising results.
机译:通过2-氯-3-甲基喹喔啉(2)的叠氮环缩合制备4-甲基四唑并[1,5-a]喹喔啉(3)。 3与芳族醛的反应提供了4-苯乙烯基四唑并[1,5-a]喹喔啉(4a-f)。用水合肼处理化合物2,得到2-肼基-3-甲基喹喔啉(5)。通过原酸酯与三氟乙酸反应得到4-甲基-1-(取代的)[1,2,4]三唑并[4,3-a]喹喔啉(7a-c)来实现5的闭环。此外,7a-c与不同的芳族醛的反应以良好的产率提供了标题化合物4-苯乙烯基-1-(取代的)[1,2,4]三唑并[4,3-a]喹喔啉(8a-i)。在另一方案中,用不同的芳族醛处理肼化合物5,得到相应的N-亚芳基肼基喹喔啉(6a-d)。此外,通过硝基苯氧化环化生成1-芳基-4-甲基[1,2,4]三唑并[4,3-a]喹喔啉(7d-g),与芳族醛缩合后得到标题化合物, 1-芳基-4-苯乙烯基[1,2,4]三唑并[4,3-a]喹喔啉(8j-u)。通过FTIR,(1)H NMR,(13)C NMR和质谱数据对新合成的化合物进行表征,然后进行元素分析。筛选了某些化合物的体内抗惊厥活性。他们中很少有人表现出令人鼓舞的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号